News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
10 22 2015 - Revenues of $1.88 billion, up 0.9% on an equivalent basis vs. 2014; down 1.3% on a reported basis vs. 2014Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the quarter ended September 30, 2015, adjusted net income was...
-
10 21 2015 Transaction to Expand Paramedical Services Offering for Insurers, Brokerages and Life Insurance ApplicantsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ExamOne business, the leader in helping insurers meet their underwriting...
-
10 09 2015 The new Quest test service is based on the first FDA-approved complementary diagnosticQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx...
-
10 08 2015 Scientists from Quest Diagnostics also provide an oral presentation on the novel "molecular combing" technique's ability to identify gene mutations to aid diagnosis of a form of muscular dystrophyGenetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a...
-
10 06 2015 Molecular test from Quest Diagnostics' products business is cleared to identify 92 influenza and respiratory syncytial virus strains, more than any other FDA-cleared molecular testIn advance of the 2015-2016 flu season, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received 510(k)...
-
10 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2015 results on Thursday, October 22, 2015,...
-
10 02 2015 Testing by Quest will advance precision medicine by helping to identify patients who may benefit from new oncology immunotherapyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the PD-L1 IHC 22C3 PharmDx™...
-
09 29 2015 "Data Diagnostics™" provides valuable on-demand insights to align clinical management with quality, utilization and financial performance goalsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based data...
-
09 14 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the eleventh consecutive year in the North America Dow Jones Sustainability Index...
-
09 11 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
-
09 10 2015 Analysis by Quest Diagnostics of 2.5 million de-identified test results finds about half of patients of all ages are still taking opioids and other potentially addictive medications inappropriatelyAlthough prescription drug misuse is on the decline among adolescents, one in two patients tested between the ages of 10 and 17 years are not using their medications appropriately, potentially...
-
09 10 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 10th Annual Wells Fargo Healthcare...
-
09 03 2015 System from Quest Diagnostics' products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collectionQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Focus Diagnostics products business has received FDA 510(k) clearance to...
-
08 18 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share,...
-
08 04 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the previously announced acquisition of MemorialCare Health...
-
07 29 2015 Educational campaign and patient registry to provide new insights and clarification on use of advanced screening tests to assess fetal health while promoting outcomes research on tests' predictive accuracyThe Perinatal Quality Foundation (PQF) today announced a nationwide campaign to improve understanding of the advantages, limitations and clinically appropriate interpretation of results of...
-
07 23 2015 - Revenues of $1.93 billion, up 1.2% from 2014Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the second quarter ended June 30, 2015, adjusted net income...
-
07 07 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2015 results on Thursday, July 23, 2015,...
-
06 30 2015 Transaction to Extend Laboratory Partnership Serving Patients and Physicians in Southern California while Bolstering Quest's Growth Strategy in the RegionQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and MemorialCare Health System, a nationally recognized nonprofit health system in Los Angeles and...
-
06 16 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Care360 cloud-based electronic health record (EHR) has ranked number one...
-
06 09 2015 Upsurge in marijuana, cocaine and methamphetamine drive second consecutive year of increases in the positivity rate for drug tests, suggesting a potential reversal in a decades' long decline in workforce drug useThe percentage of American workers testing positive for illicit drugs such as marijuana, cocaine and methamphetamine has increased for the second consecutive year in the general U.S. workforce,...
-
06 09 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that, in light of recent progress in finalizing its clinical trials joint...
-
06 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 2015 Global Healthcare...
-
05 28 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies 2015 Global Healthcare...
-
05 15 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share,...
-
05 12 2015 New prenatal screening service provides actionable information for women with high-risk pregnanciesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services and a leader in women's health and genomic testing, today launched QNatal Advanced, a noninvasive...
-
05 04 2015 Quest Diagnostics Announces LeukoVantage™, Advancing Precision Medicine for Hematologic MalignanciesGenomic service detects 30 gene mutations to aid in the diagnosis, prognosis, monitoring and treatment selection for several myeloid neoplasmsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced LeukoVantage™, an evidence-based genomic test service that aids in the diagnosis,...
-
04 23 2015 -- Revenues of $1.84 billion, up 5.3% from 2014Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2015, adjusted net income...
-
04 21 2015 BRCA Share™ is a novel public-private initiative designed to enhance the clarity and quality of patient testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Inserm, the French National Institute of Health and Medical Research institution, today launched...
-
04 15 2015 Focus Diagnostics, the clinical-laboratory products business of Quest Diagnostics (NYSE: DGX), today announced the FDA 510(k) clearance and CLIA moderate-complexity categorization for its Simplexa...
-
04 14 2015 As many as 19% of women received false negatives for cervical cancer when HPV-only tested, finds Quest Diagnostics Health Trends™ study published in Cancer Cytopathology of 256,648 women, one of the largest of different screening tests for cervical cancerHPV-only screening is less likely to accurately detect cervical pre-cancer and cancer than testing that includes a Pap test in women 30-65 years of age, according to a new study published online...
-
04 13 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2015 results on Thursday, April 23, 2015,...
-
04 09 2015 Company's HIT solutions turn health information into actionable insights to help ACOs, health systems, hospitals and physicians improve health care quality, outcomes and efficienciesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will unveil a suite of new technology solutions during the HIMSS 2015 Annual Conference &...
-
04 02 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2015 Supplier Forum. Supplier...
-
03 23 2015 Quest Diagnostics Health Trends™ study in Diabetes Care suggests health care reform has increased access to preventive health services, but only in states that expanded MedicaidPeople in states that expanded Medicaid under the Affordable Care Act (ACA) are far more likely to be newly identified with diabetes than in states that elected not to expand the public health...
-
03 19 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the early tender results of its previously announced cash tender offers...
-
03 18 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the determination of the pricing for its previously announced cash...
-
03 10 2015 Proprietary Neurome™ service provides insight into the genetic causes of neurological disorders so parents and health care providers can develop personalized care strategiesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of Neurome™, a whole exome sequencing service designed to aid the...
-
03 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it is amending the terms of its cash tender offers (each, an...
-
03 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $1,200,000,000 in aggregate principal amount...
-
03 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has commenced cash tender offers (each, an "Offer" and,...
-
03 04 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in...
-
02 20 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named a "Most Admired Company" by Fortune Magazine in the "Health...
-
02 09 2015 Agreement ensures continuing broad patient access to Quest's BRCAvantage™ services for evaluating genetic risk of developing breast, ovarian and other cancersQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA...
-
01 29 2015 Fourth quarter revenues from continuing operations of $1.9 billion, up 7.2% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 4.9% versus prior year Reported diluted...
-
01 28 2015 Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million Americans with viral hepatitisQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention (CDC)...
-
01 13 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2014 results on Thursday,...
-
01 08 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the appointment of veteran health plan executive Michael Cole as vice president of...
-
01 06 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 33rd Annual J.P. Morgan Healthcare...
-
01 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs Healthcare CEOs Unscripted...